Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000243819

Medchemexpress LLC PMX-53 | 219639-75-5 | MFCD07363866 | 99.9% | 896.09 | C47H65N11O7 | 50 MG
SDP

Catalog No. 5000243819
Encompass_Preferred

PMX-53 is a synthetic peptidic antagonist of the complement C5a receptor (C5aR1/CD88). It is orally active and is used in preclinical research on inflammation, cancer, and atherosclerosis. Reported potency at C5aR1 is approximately 20 nM, and analytical data and storage recommendations are provided with the product documentation.

  • Peptidic C5a receptor antagonist.
  • Orally active, suitable for in vivo and in vitro studies.
  • Potent activity against C5aR1 (IC50 ≈ 20 nM).
  • Selective for C5aR1 over C5L2 and C3aR.
  • Characterized sequence and molecular weight for analytical use.
  • COA available with storage recommendations to preserve stability.

Catalog No. 50-002-43819 Supplier Medchemexpress LLC Supplier No. HY10617850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

PMX-53 is a synthetic peptidic antagonist of the complement C5a receptor (C5aR1/CD88). It is orally active and is used in preclinical research on inflammation, cancer, and atherosclerosis. Reported potency at C5aR1 is approximately 20 nM, and analytical data and storage recommendations are provided with the product documentation.

  • Peptidic C5a receptor antagonist.
  • Orally active, suitable for in vivo and in vitro studies.
  • Potent activity against C5aR1 (IC50 ≈ 20 nM).
  • Selective for C5aR1 over C5L2 and C3aR.
  • Characterized sequence and molecular weight for analytical use.
  • COA available with storage recommendations to preserve stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.